Elicio Therapeutics, Inc. H-1B Visa Sponsorship 2026
Research and Development in Biotechnology · H-1B sponsor · FY2017–2026
📍 Boston, MA most H-1B filings
Does Elicio Therapeutics, Inc. sponsor H-1B visas?
Yes. Elicio Therapeutics, Inc. has filed 3 H-1B LCAs with the U.S. Department of Labor between FY2020 and FY2026. In FY2023 Elicio Therapeutics, Inc. filed 1 H-1B LCA at a median base salary of $102,198. No PERM green-card cases are on record.
It files most often for Associate Scientist I roles, most in Boston, MA.
H-1B filings
3
(FY2020–2023)
Median base pay
$102k
from 1 filing (FY2023)
Pay vs market
-7%
below national median ($110k, FY2023)
Green-card (PERM) filings
0
no green-card cases
H-1B pay & filings by year
Median base salary (line) and H-1B filing volume (bars), by fiscal year
Show the numbers behind this chart
| Fiscal year | H-1B LCA filings | Median base salary |
|---|---|---|
| FY2023 | 1 | $102k |
| FY2022 | 1 | $105k |
| FY2020 | 1 | $83k |
H-1B wage floor & filing outcomes
What this employer pays against the DOL legal minimum, how senior the roles are, and how the filings were decided
Pay vs the legal floor
$102k
18% above the $87k prevailing wage
Role seniority (wage levels)
100% entry to mid
L II
3
LCA decisions
100.0% certified
3 of 3 filings
USCIS I-129 petition outcomes · FY2017–2023
Approved1 petitions
Denied0 petitions
LCA filings by type · FY2020–2023
New employment2 filings66.7%
Transfers in0 filings0%
Renewals1 filings33.3%
Roles they file for
Where they hire
By city
Worker backgrounds
From green-card (PERM) cases
Sponsors H-1B workers but has few or no green-card (PERM) cases under this name, so worker backgrounds aren’t available.
Patents
- Granted
- 4
- US patents
- Published, not yet granted
- 13
- applications
- Most recent grant
- July 29, 2025
- Top area
- Preparations for medical2
Other top areas
Peptides1Microorganisms or enzymes; compositions thereof; propagating1
About Elicio Therapeutics, Inc.
- Name (DOL filings)
- Elicio Therapeutics, Inc.
- Listed
- —
- Sponsoring since
- FY2020
- Main filing location
- Boston, MA
- Industry (NAICS)
- Research and Development in Biotechnology
- Employees (global)
- —
- H-1B filings
- 3
- Median base
- $102,198
- R&D
- —
H-1B sponsors similar to Elicio Therapeutics, Inc.
| Employer | Filings, all years | Recent filings | Median base | New employment | Level III-IV roles |
|---|---|---|---|---|---|
| Adimab Service Company | 15 | 7 | $146k | 5 | — |
| Colossal Biosciences | 15 | 4 | $128k | 2 | — |
| Generation Bio Co. | 15 | 3 | $155k | 0 | — |
| Enveda Therapeutics | 14 | 6 | $184k | 2 | — |
| Hansoh Bio | 14 | 6 | $103k | 1 | — |
| Neuro42 | 14 | 4 | $124k | 2 | — |
| Elicio Therapeutics, Inc. | 3 | 0 | — | 0 | — |
